Literature DB >> 23255577

Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.

Michael Zeisberg1, Raghu Kalluri.   

Abstract

Fibrosis is a pathological scarring process that leads to destruction of organ architecture and impairment of organ function. Chronic loss of organ function in most organs, including bone marrow, heart, intestine, kidney, liver, lung, and skin, is associated with fibrosis, contributing to an estimated one third of natural deaths worldwide. Effective therapies to prevent or to even reverse existing fibrotic lesions are not yet available in any organ. There is hope that an understanding of common fibrosis pathways will lead to development of antifibrotic therapies that are effective in all of these tissues in the future. Here we review common and organ-specific pathways of tissue fibrosis.

Entities:  

Mesh:

Year:  2012        PMID: 23255577      PMCID: PMC3566435          DOI: 10.1152/ajpcell.00328.2012

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  139 in total

1.  Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts.

Authors:  M Iwano; A Fischer; H Okada; D Plieth; C Xue; T M Danoff; E G Neilson
Journal:  Mol Ther       Date:  2001-02       Impact factor: 11.454

Review 2.  Structural and functional coupling of cardiac myocytes and fibroblasts.

Authors:  Patrizia Camelliti; Colin R Green; Peter Kohl
Journal:  Adv Cardiol       Date:  2006

3.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

4.  MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats.

Authors:  Hui Tao; Cheng Huang; Jing-Jing Yang; Tao-Tao Ma; Er-Bao Bian; Lei Zhang; Xiong-Wen Lv; Yong Jin; Jun Li
Journal:  Toxicology       Date:  2011-10-25       Impact factor: 4.221

Review 5.  Molecular regulation of atrioventricular valvuloseptal morphogenesis.

Authors:  L M Eisenberg; R R Markwald
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

6.  Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF.

Authors:  A B Roberts; M A Anzano; L C Lamb; J M Smith; C A Frolik; H Marquardt; G J Todaro; M B Sporn
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

Review 7.  Origins of cardiac fibroblasts.

Authors:  Elisabeth M Zeisberg; Raghu Kalluri
Journal:  Circ Res       Date:  2010-11-26       Impact factor: 17.367

8.  Genetic polymorphisms of transforming growth factor beta-1 promoter and primary biliary cirrhosis in Japanese patients.

Authors:  Kentaro Kikuchi; Atsushi Tanaka; Masanao Matsushita; Eriko Kitazawa; Naomi Hosoya; Yumi Kawashima; Carlo Selmi; M Eric Gershwin; Hiroshi Miyakawa
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

9.  Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat.

Authors:  S Vukicevic; V Basic; D Rogic; N Basic; M S Shih; A Shepard; D Jin; B Dattatreyamurty; W Jones; H Dorai; S Ryan; D Griffiths; J Maliakal; M Jelic; M Pastorcic; A Stavljenic; T K Sampath
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  Osteogenic Protein-1: gene expression and treatment in rat remnant kidney model.

Authors:  Philip H Dube; Maria M Almanzar; Kendall S Frazier; William K Jones; Marc F Charette; Ana Paredes
Journal:  Toxicol Pathol       Date:  2004 Jul-Aug       Impact factor: 1.902

View more
  148 in total

1.  Fra-2-expressing macrophages promote lung fibrosis in mice.

Authors:  Alvaro C Ucero; Latifa Bakiri; Ben Roediger; Masakatsu Suzuki; Maria Jimenez; Pratyusha Mandal; Paola Braghetta; Paolo Bonaldo; Luis Paz-Ares; Coral Fustero-Torre; Pilar Ximenez-Embun; Ana Isabel Hernandez; Diego Megias; Erwin F Wagner
Journal:  J Clin Invest       Date:  2019-05-28       Impact factor: 14.808

2.  miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.

Authors:  Marta Fierro-Fernández; Óscar Busnadiego; Pilar Sandoval; Cristina Espinosa-Díez; Eva Blanco-Ruiz; Macarena Rodríguez; Héctor Pian; Ricardo Ramos; Manuel López-Cabrera; Maria Laura García-Bermejo; Santiago Lamas
Journal:  EMBO Rep       Date:  2015-08-27       Impact factor: 8.807

3.  Overexpression of inhibitor of DNA-binding 2 attenuates pulmonary fibrosis through regulation of c-Abl and Twist.

Authors:  Jibing Yang; Miranda Velikoff; Manisha Agarwal; Supparerk Disayabutr; Paul J Wolters; Kevin K Kim
Journal:  Am J Pathol       Date:  2015-02-03       Impact factor: 4.307

Review 4.  Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.

Authors:  David Lu; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-18       Impact factor: 4.249

Review 5.  Physiology of the Renal Interstitium.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-26       Impact factor: 8.237

6.  AJP-Cell theme on "Cell Signaling: Proteins, Pathways and Mechanisms".

Authors:  Josephine C Adams
Journal:  Am J Physiol Cell Physiol       Date:  2015-02-01       Impact factor: 4.249

7.  AMP-activated protein kinase/myocardin-related transcription factor-A signaling regulates fibroblast activation and renal fibrosis.

Authors:  Yuguo Wang; Li Jia; Zhaoyong Hu; Mark L Entman; William E Mitch; Yanlin Wang
Journal:  Kidney Int       Date:  2017-07-21       Impact factor: 10.612

Review 8.  Molecular imaging of fibrosis: recent advances and future directions.

Authors:  Sydney B Montesi; Pauline Désogère; Bryan C Fuchs; Peter Caravan
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

Review 9.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

Review 10.  The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction.

Authors:  Robert L Chevalier
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.